Ventricular Assist Devices (VAD)

St. Jude Medical and Thoratec announced that the boards of directors of both companies have unanimously approved a definitive agreement under which St. Jude Medical will acquire all of the outstanding shares of Thoratec. The agreement sets the pri...

Thoratec announced that the HeartMate PHP (Percutaneous Heart Pump) received CE Mark approval, permitting sale in the European Union and other international countries. Approval was based on data from the first 30 patients enrolled in the HeartMate...

Impella, FDA, high risk PCI

The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for Abiomed’s Impella 2.5 heart pump during elective and urgent high-risk percutaneous coronary intervention (PCI) procedures.

July 18, 2014 — The Freedom portable driver has received U.S. Food and Drug Administration (FDA) approval for use with the SynCardia temporary total artificial heart as a bridge to transplantation in cardiac transplant candidates who are clinicall...

St. Jude Medical, acquires shares, Thoratec, heart failure, agreement
St. Jude Medical and Thoratec announced that the boards of directors of both companies have unanimously approved a definitive agreement under which St. Jude...
Thoratec, HeartMate PHP. CE Mark approval, SHIELD I
Thoratec announced that the HeartMate PHP (Percutaneous Heart Pump) received CE Mark approval, permitting sale in the European Union and other international...
Abiomed, U.S. headquarters expansion, Impella 2.5, RP, jobs
During an event with Massachusetts Gov. Charlie Baker in June, Abiomed announced a major expansion of its U.S. headquarters in Danvers, Massachusetts, and the...
ECRI Institute, review, Impella RP, Abiomed
ECRI Institute recently reviewed published data on Abiomed’s Impella RP (Right Percutaneous) transcatheter ventricular assist device (VAD). The institute said...
Impella, FDA, high risk PCI, abiomed
Abiomed’s Impella 2.5 heart pump has gained an additional FDA vindication for use during elective and urgent high-risk percutaneous
CardiacAssist's Protek Duo veno‐venous cannula is intended for use as a single cannula for both venous drainage and reinfusion of...
SynCardia SynHall valves, use in the SynCardia Heart, are of the same design, materials and nearly identical manufacturing processes as the...
The Freedom portable driver is U.S. Food and Drug Administration (FDA)-approved for use with the SynCardia temporary total artificial heart...

Articles

St. Jude Medical, acquires shares, Thoratec, heart failure, agreement
St. Jude Medical and Thoratec announced that the boards of directors of both companies have unanimously approved a definitive agreement under which St. Jude...
Thoratec, HeartMate PHP. CE Mark approval, SHIELD I
Thoratec announced that the HeartMate PHP (Percutaneous Heart Pump) received CE Mark approval, permitting sale in the European Union and other international...
expert consensus, SCAI, ACC, HFSA, STS, heart pumps, MCS devices
An expert consensus statement released by four leading cardiovascular societies provides new guidance on percutaneous mechanical circulatory support (MCS)...
Impella, FDA, high risk PCI, abiomed
The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for Abiomed’s Impella 2.5 heart pump during elective and urgent...

Video Center

Here are a few observations on cardiovascular ultrasound advances I made while attending the 2015...
4 weeks 1 day ago
The latest advances in cardiovascular echocardiography will be presented at the 2015 American...
6 weeks 4 days ago
There were several technology takeaway messages for the future of electrophysiology (EP) at the...
9 weeks 4 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...